Edition:
United Kingdom

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

66.00USD
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
$66.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
72,308
52-wk High
$66.01
52-wk Low
$25.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.50 September 19 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 3 3 3
(3) HOLD 2 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 3 17.80 21.00 12.93 --
Quarter Ending Jun-18 3 18.74 21.00 15.24 --
Year Ending Sep-18 4 85.94 97.00 69.44 --
Year Ending Sep-19 2 103.79 124.00 83.57 --
Earnings (per share)
Quarter Ending Mar-18 2 -0.50 -0.24 -0.75 --
Quarter Ending Jun-18 2 -0.57 -0.37 -0.77 --
Year Ending Sep-18 4 -1.24 -0.46 -2.36 --
Year Ending Sep-19 2 -0.82 -0.62 -1.03 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 73.80 75.93 2.13 2.88
Quarter Ending Jun-17 8.07 7.51 0.56 6.98
Quarter Ending Mar-17 9.19 8.96 0.23 2.53
Quarter Ending Dec-16 11.94 10.42 1.52 12.72
Quarter Ending Sep-16 13.22 12.84 0.38 2.90

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 17.80 17.80 17.08 12.93 --
Quarter Ending Jun-18 18.74 18.74 18.85 15.24 --
Year Ending Sep-18 85.94 85.94 85.18 69.92 --
Year Ending Sep-19 103.79 103.79 102.20 76.75 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 1 0
Quarter Ending Jun-18 0 0 0 1
Year Ending Sep-18 0 0 1 0
Year Ending Sep-19 0 0 1 0
Earnings